Ahmed F Al Jebawi, MD | |
141 W 22nd St Ste 210, Anderson, IN 46016-4389 | |
(765) 646-8795 | |
Not Available |
Full Name | Ahmed F Al Jebawi |
---|---|
Gender | Male |
Speciality | Endocrinology |
Experience | 35 Years |
Location | 141 W 22nd St Ste 210, Anderson, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306839030 | NPI | - | NPPES |
200184910A | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 01048401A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension St Vincent Anderson | Anderson, IN | Hospital |
Community Hospital Of Anderson And Madison County | Anderson, IN | Hospital |
Marion General Hospital | Marion, IN | Hospital |
Ascension St Vincent Randolph | Winchester, IN | Hospital |
Henry County Memorial Hospital | New castle, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
Baylor College of Medicine scientists defined a previously unrecognized genetic cause for two types of birth defects found in newborn boys, described in a report published today in the journal Nature Medicine.
The LSU Health New Orleans School of Public Health has been awarded a $2.2 million grant to increase the availability of health information and support services for young breast cancer survivors in the Gulf South.
Novavax, Inc. announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no longer on clinical hold. In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved.
The state Senate will be considering a bill that would make it possible for nonpublic schools to include technology-based learning materials in the curriculum for students with special needs. The bill recently passed the state Assembly (76-0) with unanimous bipartisan support.
The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).
› Verified 3 days ago
Entity Name | St Vincent Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
Baylor College of Medicine scientists defined a previously unrecognized genetic cause for two types of birth defects found in newborn boys, described in a report published today in the journal Nature Medicine.
The LSU Health New Orleans School of Public Health has been awarded a $2.2 million grant to increase the availability of health information and support services for young breast cancer survivors in the Gulf South.
Novavax, Inc. announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no longer on clinical hold. In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved.
The state Senate will be considering a bill that would make it possible for nonpublic schools to include technology-based learning materials in the curriculum for students with special needs. The bill recently passed the state Assembly (76-0) with unanimous bipartisan support.
The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Ahmed F Al Jebawi, MD 141 W 22nd St Ste 210, Anderson, IN 46016-4389 Ph: () - | Ahmed F Al Jebawi, MD 141 W 22nd St Ste 210, Anderson, IN 46016-4389 Ph: (765) 646-8795 |
News Archive
Baylor College of Medicine scientists defined a previously unrecognized genetic cause for two types of birth defects found in newborn boys, described in a report published today in the journal Nature Medicine.
The LSU Health New Orleans School of Public Health has been awarded a $2.2 million grant to increase the availability of health information and support services for young breast cancer survivors in the Gulf South.
Novavax, Inc. announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no longer on clinical hold. In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved.
The state Senate will be considering a bill that would make it possible for nonpublic schools to include technology-based learning materials in the curriculum for students with special needs. The bill recently passed the state Assembly (76-0) with unanimous bipartisan support.
The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).
› Verified 3 days ago
Mark Randall Jennings, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-649-2511 | |
Dr. Dalwinderpal Singh Samra, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1547 Ohio Ave., Anderson, IN 46016 Phone: 609-694-8566 | |
Ubaidullah Sharief, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2020 Meridian St Ste 100, Anderson, IN 46016 Phone: 765-646-8509 | |
Adam L Greene, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Chad Michael Feldman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Dr. Edgardo Manuel Flores Anticona, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 110, Anderson, IN 46016 Phone: 765-643-6012 Fax: 765-646-9054 | |
Kristine M Rea, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 212, Anderson, IN 46016 Phone: 765-648-4138 |